AGTR2 and carcinoma: Furthermore, the AT2 receptor blockade using PD123319 in animal in vivo models of fibrosarcoma and LL/2 cells carcinoma delayed tumorigenesis by inhibiting malignant cell proliferation and angiogenesis as well [69].